Abstract Topics

Abstract Topics

View abstract topics below and start preparing your abstract.

The MDS Foundation will award $1,000 travel grants to the top 10 abstracts led by early career authors.

Flow cytometry
Molecular aberrations (cytogenetic, genetic, gene expression)

Cost of care
Patient-reported outcomes
Efficacy outcome measures

Normal, MDS, and leukemic stem cells
Clonal diversity & evolution
MDS Mouse models (GEMMS, PDX)
Somatic mutations
Spliceosome machinery
Gene expression profiling
Epigenetic deregulation
Immune deregulation / inflammation
Microenvironment and stem cell niche

Prognostic factors of outcome and risk assessment
Predictive factors of response to treatment

MDS in childhood
Hereditary MDS including predisposition syndromes
MDS with ring sideroblasts
Chronic myelomonocytic leukemia and overlap syndromes (MDS – MPN)
MDS with deletion 5q
Treatment-related MDS

Current treatment options – Higher risk MDS
Current treatment options – Lower risk MDS
Current treatment options -Immunosuppressive therapy
New developments – Preclinical studies
New developments – Phase I studies
Clinical trials – Phase II-III
Allogeneic hematopoietic cell transplantation -Bridging to transplantation
Allogeneic hematopoietic cell transplantation -Post-transplantation treatment
observational studies
Supportive care, transfusion medicine and MDS, iron overload
Supportive care, Geriatric issues and MDS

Disease experiences